$80.97
-1.25-1.51%
At Close: -
$80.97
00.00%
After Hours: 1:00 PM EDT
15 minutes delayed
Biomarin Pharmaceutical
BMRNNASDAQ
Biomarin Pharmaceutical (NASDAQ:BMRN) Stock, Earnings Estimates, EPS, And Revenue
Biomarin Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 29
EPS Estimate
$0.340
Quarterly Revenue Estimate
$661.2M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.5B
Analyze the earnings history of Biomarin Pharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical | $0.54 | $0.34 | — | — | $595.27M | $661.23M | — | — | 07/29/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.60 | $0.34 | $0.71 | 108.82% | $596.41M | $651.79M | $648.83M | -0.45% | 04/24/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.00 | $0.23 | $0.49 | 113.04% | $537.54M | $636.67M | $646.21M | 1.50% | 02/22/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.04 | $0.22 | $0.46 | 109.09% | $505.34M | $608.33M | $581.33M | -4.44% | 11/01/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.15 | $0.47 | $0.54 | 14.89% | $533.80M | $591.46M | $595.27M | 0.65% | 07/31/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.63 | $0.18 | $0.60 | 233.33% | $519.36M | $570.62M | $596.41M | 4.52% | 04/26/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.32 | -$0.07 | $0.00 | 100.00% | $449.81M | $536.97M | $537.54M | 0.11% | 02/27/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.20 | -$0.01 | -$0.04 | -300.00% | $408.74M | $518.91M | $505.34M | -2.61% | 10/26/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.07 | $0.11 | $0.59 | 436.36% | $501.69M | $521.47M | $533.80M | 2.36% | 08/03/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.09 | — | $0.17 | — | $486.03M | $507.52M | $519.36M | 2.33% | 04/27/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.12 | -$0.32 | -$0.32 | 0.00% | $452.12M | $442.39M | $449.81M | 1.68% | 02/23/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $4.01 | -$0.25 | -$0.20 | 20.00% | $476.78M | $435.32M | $408.74M | -6.11% | 10/27/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.16 | -$0.11 | $0.07 | 163.64% | $429.49M | $448.79M | $501.69M | 11.79% | 07/28/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.44 | -$0.10 | $0.09 | 190.00% | $502.07M | $446.45M | $486.03M | 8.87% | 04/29/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.08 | -$0.19 | $0.12 | 163.16% | $454.44M | $440.23M | $452.12M | 2.70% | 02/25/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.30 | $1.29 | $4.01 | 210.85% | $461.10M | $454.64M | $476.78M | 4.87% | 11/05/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.29 | -$0.11 | -$0.16 | -45.45% | $387.76M | $418.61M | $429.49M | 2.60% | 08/04/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.32 | $0.05 | $0.44 | 780.00% | $400.75M | $468.77M | $502.07M | 7.10% | 04/29/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.03 | -$0.09 | $0.08 | 188.89% | $353.21M | $459.33M | $454.44M | -1.06% | 02/26/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.07 | $0.07 | $0.30 | 328.57% | $391.71M | $454.22M | $461.10M | 1.51% | 10/23/2019 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.09 | -$0.10 | -$0.29 | -190.00% | $372.85M | $414.40M | $387.76M | -6.43% | 08/01/2019 | Get Alert |
Biomarin Pharmaceutical (BMRN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-24 | $0.71 | $0.34 | 108.8 % |
| Dec 2023 | 2024-02-22 | $0.49 | $0.23 | 113.0 % |
| Sep 2023 | 2023-11-01 | $0.46 | $0.22 | 109.1 % |
| Jun 2023 | 2023-07-31 | $0.54 | $0.47 | 14.9 % |
Biomarin Pharmaceutical (BMRN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-24 | $648.83M | $651.79M | -0.45 % |
| Dec 2023 | 2024-02-22 | $646.21M | $636.67M | 1.50 % |
| Sep 2023 | 2023-11-01 | $581.33M | $608.33M | -4.44 % |
| Jun 2023 | 2023-07-31 | $595.28M | $591.46M | 0.65 % |
FAQ
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical (BMRN) is scheduled to report earnings on July 29, 2024. The last reported earnings were for reported on April 24, 2024 for Q1.
What were the latest earnings per share (EPS) for Biomarin Pharmaceutical (NASDAQ:BMRN)?
The Actual EPS was $0.71, which beat the estimate of $0.34.
What were Biomarin Pharmaceutical’s (NASDAQ:BMRN) revenues?
The Actual Revenue was $648.8M, which missed the estimate of $651.8M.
Browse earnings estimates, EPS, and revenue on all stocks.